Bio Protocol

Bio Protocol

Private
Zug, ZugCrypto & Web3https://www.bio.xyz

Last Round

Seed

Sep 17, 2025

Total Funding Raised

$6.9M

Company Overview

Bio Protocol is a decentralized science (DeSci) platform that utilizes AI and blockchain technology to facilitate the funding, development, and commercialization of biotechnology research. The company enables researchers, patients, and investors to form and support BioDAOs (Decentralized Autonomous Organizations), which are community-owned networks dedicated to specific areas of scientific research. This model aims to democratize access to research funding, accelerate innovation in areas like drug discovery, and allow for collective ownership of the resulting intellectual property. Bio Protocol generates revenue by receiving a token allocation from new projects launched on its platform and by earning fees from the management of token trading and liquidity pools. The platform recently raised $6.9 million in a seed funding round to expand its AI-native infrastructure.

Sector

Crypto & Web3

Verticals

Biotechnology, Drug Discovery, Tokenization, DeFi, DAOs

Business Model

B2B2C

Customer Profile

Marketplace Commission, Revenue Share

AI Layer

Application

Keywords

decentralized scienceDeScibiotech launchpadIP-NFTsIP tokenizationBioDAOsbiotech fundingdecentralized AI agentsdrug discoverycommunity crowdfundingscientific research marketplaceYC of DeScilongevity researchrare disease research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bio Protocol Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Bio Protocol Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedSep 17, 2025

Bio Protocol Investors

Notable investors and investment history

Bio Protocol Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bio Protocol Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bio Protocol's valuation, stock price, and market status.

Firmographic Details

HeadquartersZug, Zug
Year Founded2022
Last FundingSep 17, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.